lenabasum
corbus pharma
['lenabasum', ' lena', 'derm']
werth et al. lenabasum phase 3 trial indermatomyositis. primary endpoint (tis week 28) not met. subgroup analysis suggest small effect on muscle and modest effect on skin disease #acr22 abstr#0173 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC